Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4347-4350

  Banáth, Judit P ^a   Olive, Peggy L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BLEOMYCIN; DNA; DOXORUBICIN; ETOPOSIDE; HISTONE ANTIBODY; HISTONE H2A; HISTONE H2AX; HYDROGEN PEROXIDE; SERINE; TIRAPAZAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CANCER CHEMOTHERAPY; CELL KILLING; CHO CELL; CLONOGENESIS; COLONY FORMATION; DNA STRAND BREAKAGE; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CELL DEATH; CELL LINE; CRICETINAE; CRICETULUS; DNA; DNA DAMAGE; DOXORUBICIN; ETOPOSIDE; FIBROBLASTS; HISTONES; HYDROGEN PEROXIDE; PHOSPHORYLATION; TRIAZINES;

EID: 0345835371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. West, C. M., Davidson, S. E., Elyan, S. A., Swindell, R., Roberts, S. A., Orton, C. J., Coyle, C. A., Valentine, H., Wilks, D. P., Hunter, R. D., and Hendry. J. H. The intrinsic radiosensitivity of normal and tumour cells. Int. J. Radiat. Biol., 73: 409-413, 1998.
2. Von Hoff, D. D. He's not going to talk about in vitro predictive assays again, is he? J. Natl. Cancer Inst. (Bethesda), 82: 96-101, 1990.
3. Von Hoff, D. D., Sandbach, J. F., Clark, G. M., Turner, J. N., Forseth, B. F., Piccart, M. J., Colombo, N., and Muggia, F. M. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J. Natl. Cancer Inst. (Bethesda), 82: 110-116, 1990.
4. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., and Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273: 5858-5868, 1998.
5. Rogakou, E. P., Boon, C., Redon, C., and Bonner, W. M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol., 146: 905-916, 1999.
6. 125IdU-induced DNA double-strand breaks with γH2AX antibody. Radiat. Res., 158: 486-492, 2002.
7. 1 phase cells. Radiat. Res., 159: 759-767, 2003.
8. MacPhail, S. H., Banáth, J. P., Yu, T. Y., Chu, E. H. M., Lambur, H., and Olive, P. L. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to x-rays. Int. J. Radiat. Biol., in press, 2003.
9. Olive, P. L., and Johnston, P. J. DNA damage from oxidants: influence of lesion complexity and chromatin organization. Oncol. Res., 9: 287-294, 1997.
10. Olive, P. L., and Banáth, J. P. Multicell spheroid response to drugs predicted with the comet assay. Cancer Res., 57: 5528-5533, 1997.
11. Olive, P. L., Vikse, C. M., and Banáth, J. P. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice. Cancer Res., 56: 4460-4463, 1996.
12. Watanabe, M., and Horikawa, M. Analyses of differential sensitivities of synchronized HeLa S3 cells to radiations and chemical carcinogens during the cell cycle. III. 4-Nitroquinoline 1-oxide and its derivatives. Mutat. Res., 28: 295-304, 1975.
13. Liu, J. S., Kuo, S. R., Beerman, T. A., and Melendy, T. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks. Mol. Cancer Ther., 2: 41-47, 2003.
14. 125IdUrd. Int. J. Radiat. Biol., 64: 349-358, 1993.